NATH BIOGENES (INDIA)
Back to Income Statement
|
NATH BIOGENES (INDIA) Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2013 | Mar2012 | |
---|---|---|---|---|---|
Adjusted EPS | ₹18.43 | ₹-35.46 | ₹7.34 | ₹5.75 | ₹5.75 |
What is the latest Earnings Per Share (EPS) of NATH BIOGENES (INDIA) ?
Year | Earnings Per Share (EPS) |
---|---|
Mar2024 | ₹18.43 |
Mar2023 | ₹-35.46 |
Mar2022 | ₹7.34 |
Mar2013 | ₹5.75 |
Mar2012 | ₹5.75 |
How is Earnings Per Share (EPS) of NATH BIOGENES (INDIA) Trending?
Years | Earnings Per Share (EPS) | % Change | |
---|---|---|---|
Mar2024 | ₹18.43 | Positive | |
Mar2023 | ₹-35.46 | Negative | |
Mar2022 | ₹7.34 | 27.65 | |
Mar2013 | ₹5.75 | 0.00 | |
Mar2012 | ₹5.75 | - |
Compare Earnings Per Share (EPS) of peers of NATH BIOGENES (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATH BIOGENES (INDIA) | ₹298.3 Cr | 9.8% | 12.4% | -12.7% | Stock Analytics | |
BOMBAY BURMAH TRADING CORPORATION | ₹12,333.2 Cr | 5.8% | 9.3% | 17.2% | Stock Analytics | |
KAVERI SEED COMPANY | ₹7,489.8 Cr | 7.9% | 33% | 99.2% | Stock Analytics | |
VENKYS (INDIA) | ₹2,300.1 Cr | 5.5% | 4.4% | 3.5% | Stock Analytics | |
BOMBAY SUPER HYBRID SEEDS | ₹1,298.6 Cr | 0.6% | -4.3% | -47.8% | Stock Analytics | |
INDO US BIOTECH | ₹322.8 Cr | -10.4% | -24.8% | -40.9% | Stock Analytics |
NATH BIOGENES (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATH BIOGENES (INDIA) | 9.8% |
12.4% |
-12.7% |
SENSEX | -2.9% |
3.1% |
1.8% |
You may also like the below Video Courses